News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM
Malak Alharbi/LinkedIn
Feb 22, 2025, 16:00

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

Malak Alharbi, PGY6 hematology oncology fellow at Roswell Park Comprehensive Cancer Center, shared an article on LinkedIn:

“Happy to share our recent publication on a case highlighting the diagnostic challenges at presentation and the therapeutic complexities of treating PRCA secondary to SMM.

We discuss the appropriate workup and explore daratumumab as a potential management option for these patients.

 Thank you Dr Hillengass Jens for your support and mentorship!”

Rare case of pure red cell aplasia secondary to smoldering multiple myeloma successfully treated with daratumumab – case report and review of the literature.

Authors: Malak Alharbi, et al.

Malak Alharbi: Diagnostic and therapeutic challenges in PRCA secondary to SMM

cancer Daratumumab fight against cancer Global fight against cancer Hillengass Jens Malak Alharbi multiple myeloma OncoDaily Oncology PRCA Roswell Park Comprehensive Cancer Center SMM
Special Coverage
Blog
Aug 5, 2025, 15:32
Sumanta Pal: Our Terrific Surgeons are Blazing New Trails for Challenging to Treat Diseases
Opinion
Aug 5, 2025, 15:01
Timothy Winschel: Excited to Share Our Recent Paper Published in Supportive Care in Cancer
Career
Aug 5, 2025, 14:16
Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology
Blog
Aug 5, 2025, 13:23
Can Exercise Change Cancer Care?
Immune Oncology
Aug 5, 2025, 13:09
FDA Fast Track for CLD-201: Stem Cell–Based Oncolytic Virus for Soft Tissue Sarcoma
Insight
Aug 5, 2025, 12:52
Chris Boshoff: Pfizer’s Updates from the Second Quarter
Blog
Aug 5, 2025, 12:52
Davit Zohrabyan: Thanks to The Max Foundation for Giving Patients a Chance to Cancer Treatment
Insight
Aug 5, 2025, 12:39
Lorlatinib as First Treatment for ALK+ Lung Cancer - ALK Positive Inc.
Blog
Aug 5, 2025, 12:38
Ryan Nipp: Symptom Severity During Cancer Treatment Using the Symptom Care at Home Digital Platform
Career
Aug 5, 2025, 12:29
Nerses Shahbazyan: Happy to Share that I Took Part in the ESMO Course for Medical Students in Valencia
Blog
Aug 5, 2025, 12:12
What Does the Tumor-Infiltrating Lymphocyte (TIL) Therapy Process Look Like - City of Hope
Insight
Aug 5, 2025, 12:08
E. Shyam P. Reddy։ Understanding and Treating HTLV-1